Description

This program provides training in the interpretation and application of the 2017 National Institute of Allergy and Infectious Disease (NIAID) Prevention of Peanut Allergy (PPA) Guidelines. Topics covered include eczema characteristics and categorization, risk stratification and feeding recommendations for the prevention of peanut allergy in infants, and practical implementation of the 2017 PPA Guidelines.

This program was created with educational grant funding from the American Academy of Allergy, Asthma, and Immunology (AAAAI). The video presented within this program was created in collaboration with the Food Allergy Research and Education (FARE) organization, as part of the Intervention to Reduce Early (Peanut) Allergy in Children (iREACH) study funded by the National Institute of Allergy and Infectious Disease (U01AI138907). There were no commercial funds used in the production of this program.

This content was created by OPENPediatrics, a peer-reviewed medical education platform for healthcare professionals. Please see www.openpediatrics.org for more information.

  Learning Objectives:  At the conclusion of this educational program, learners will be able to:

1. Classify severity of pediatric eczema based on description and/or pictures.
2. List the three recommendations for early peanut introduction for the prevention of peanut allergy based on risk stratification as outlined by the 2017 PPA Guidelines.
3. Apply the 2017 PPA Guideline recommendations to fictional patient cases.

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Physician

Boston Children’s Hospital designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Disclosure Policy 

Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: